To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FARP1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
418 representative clones for gene FARP1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC071592 Placenta, normal FARP1.a 1 to 4915 1 to 4916 H644Y I765M tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 4916/4916
(100 %)
9 diff
(99.9 %id)
DA328266 hippocampus FARP1.a 79 to 653 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA236350 brain FARP1.a 81 to 668 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
DA797285 brain FARP1.a 102 to 664 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
CN291620 embryonic stem cells, cell lines H1, H7, andH9 FARP1.a 142 to 701 1 to 560       560/560
(100 %)
0 diff
(100 %id)
CN291624 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells FARP1.a 366 to 901 1 to 537       537/537
(100 %)
2 diff
(99.7 %id)
AL537488 brain, fetal brain FARP1.a 411 to 882 1 to 473       473/473
(100 %)
3 diff
(99.4 %id)
BX337593 Placenta Cot 25-normalized FARP1.a 411 to 885 1 to 475       475/475
(100 %)
3 diff
(99.4 %id)
BE835601 prostate_normal FARP1.a 424 to 740 354 to 38       317/354
(89 %)
4 diff
(98.9 %id)
DA791230 brain FARP1.a 480 to 1056 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
CA389987 eye, RPE/choroid FARP1.a 503 to 1053 1 to 551       551/551
(100 %)
0 diff
(100 %id)
DR763338 embryonic stem FARP1.a 562 to 1367 1 to 806       806/806
(100 %)
3 diff
(99.7 %id)
CF124975 Chondrosarcoma Lung Metastasis cell lines, lung FARP1.a 585 to 1249 1 to 663       663/663
(100 %)
3 diff
(99.6 %id)
TI_154186348   FARP1.a 585 to 1328 44 to 785       742/746
(99 %)
6 diff
(99.2 %id)
BG767698 melanotic melanoma, high MDR (cell line), skin FARP1.a 674 to 1578 1 to 889       889/891
(99 %)
27 diff
(97.0 %id)
BG747792 eye, normal pigmented retinal epithelium FARP1.a 677 to 1478 1 to 804       804/804
(100 %)
7 diff
(99.2 %id)
BG825738 muscle, rhabdomyosarcoma FARP1.a 700 to 1379 1 to 680       680/680
(100 %)
3 diff
(99.6 %id)
AW411445 muscle, rhabdomyosarcoma FARP1.a 701 to 1251 10 to 560     Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 551/560
(98 %)
6 diff
(99.0 %id)
DB216522 trachea FARP1.a 748 to 1253 2 to 507   capped   506/506
(100 %)
0 diff
(100 %id)
BX327170 Placenta Cot 25-normalized FARP1.a 756 to 1588 1 to 830       830/899
(92 %)
11 diff
(98.8 %id)
CN291625 embryonic stem cells, DMSO-treated H9 cellline FARP1.a 760 to 1301 1 to 542       542/542
(100 %)
0 diff
(100 %id)
BQ881649 brain, neuroblastoma, cell line FARP1.a 783 to 1695 1 to 912       912/912
(100 %)
8 diff
(99.2 %id)
DA781612 brain FARP1.a 791 to 1351 2 to 564   capped   563/564
(99 %)
4 diff
(99.3 %id)
CX762495 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass FARP1.a 804 to 1491 1 to 687     Submitted on the opposite strand 687/692
(99 %)
1 diff
(99.9 %id)
CO245608 Chondrosarcoma Lung Metastasis cell lines, lung FARP1.a 823 to 1563 1 to 736       736/776
(94 %)
17 diff
(97.9 %id)
BE745887 adenocarcinoma cell line, ovary FARP1.a 851 to 1637 1 to 784       784/898
(87 %)
18 diff
(98.0 %id)
BE174490 head_neck FARP1.a 861 to 1090 272 to 39     Submitted on the opposite strand 234/285
(82 %)
14 diff
(95.1 %id)
BF206873 brain, neuroblastoma FARP1.a 890 to 1654 1 to 762       762/968
(78 %)
37 diff
(96.2 %id)
BF314265 brain, neuroblastoma FARP1.a 890 to 1646 1 to 743       743/934
(79 %)
25 diff
(97.4 %id)
BE260677 brain, neuroblastoma FARP1.a 910 to 1754 1 to 842       842/865
(97 %)
21 diff
(97.6 %id)
BP337716 coronary artery FARP1.a 942 to 1523 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AW067970 Bone, Hip FARP1.a 949 to 1367 1 to 419       419/419
(100 %)
1 diff
(99.8 %id)
BP364463 lung FARP1.a 1015 to 1594 1 to 579       579/584
(99 %)
3 diff
(99.5 %id)
BU539080 adenocarcinoma, cell line, breast FARP1.a 1050 to 1999 1 to 957       955/959
(99 %)
25 diff
(97.4 %id)
DA808364 brain FARP1.a 1127 to 1699 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA224958 brain FARP1.a 1150 to 1769 2 to 621   capped   620/620
(100 %)
0 diff
(100 %id)
CX781945 human embryonic stem cells FARP1.a 1162 to 1961 1 to 800       800/800
(100 %)
2 diff
(99.8 %id)
BG829192 muscle, rhabdomyosarcoma FARP1.a 1166 to 1930 1 to 771       771/835
(92 %)
13 diff
(98.5 %id)
BU846495 ovary, teratocarcinoma, cell line FARP1.a 1206 to 2110 1 to 915       915/916
(99 %)
12 diff
(98.7 %id)
BU931960 ovary, teratocarcinoma, cell line FARP1.a 1206 to 2099 1 to 897       894/904
(98 %)
6 diff
(99.4 %id)
BG769615 melanotic melanoma, high MDR (cell line), skin FARP1.a 1209 to 1913 1 to 704       704/704
(100 %)
13 diff
(98.2 %id)
TI_57147919   FARP1.a 1296 to 2071 69 to 845       777/845
(91 %)
7 diff
(99.2 %id)
BI760610 pooled colon, kidney, stomach FARP1.a 1299 to 2071 1 to 774       774/774
(100 %)
1 diff
(99.9 %id)
BX354921 Neuroblastoma Cot 25-normalized FARP1.a 1301 to 2303 1 to 1000       1000/1000
(100 %)
9 diff
(99.1 %id)
BX364606 Neuroblastoma Cot 25-normalized FARP1.a 1301 to 2269 1 to 968       968/968
(100 %)
1 diff
(99.9 %id)
BG323704 Kidney, renal cell adenocarcinoma FARP1.a 1336 to 2129 1 to 783       784/942
(83 %)
18 diff
(98.1 %id)
BF922847 nervous_tumor FARP1.a 1337 to 1521 182 to 1     Submitted on the opposite strand 182/182
(100 %)
4 diff
(97.9 %id)
BG763918 melanotic melanoma, high MDR (cell line), skin FARP1.a 1361 to 2142 1 to 784       784/784
(100 %)
5 diff
(99.4 %id)
BE910036 epithelioid carcinoma, Pancreas FARP1.a 1382 to 2144 1 to 766       766/902
(84 %)
11 diff
(98.8 %id)
CN291631 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells FARP1.a 1408 to 2144 1 to 738       738/745
(99 %)
4 diff
(99.5 %id)
CN291616 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FARP1.a 1538 to 2088 1 to 552       552/552
(100 %)
1 diff
(99.9 %id)
BQ672632 epidermoid carcinoma, cell line, salivary gland FARP1.a 1557 to 2381 1 to 828       828/896
(92 %)
18 diff
(98.0 %id)
AA226745 brain, neuroepithelial cells FARP1.a 1573 to 1671 1 to 99       99/99
(100 %)
0 diff
(100 %id)
CN291627 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FARP1.a 1711 to 2223 1 to 513       513/513
(100 %)
0 diff
(100 %id)
BG475554 melanotic melanoma, skin FARP1.a 1770 to 2753 1 to 900       842/901
(93 %)
23 diff
(97.5 %id)
BQ331885 lung_tumor FARP1.a 1892 to 2504 616 to 6       611/618
(98 %)
7 diff
(98.9 %id)
BM728340 eye, fetal eye FARP1.a 1914 to 2367 1 to 454       454/454
(100 %)
0 diff
(100 %id)
BE812222 amnion_normal FARP1.a 1917 to 2275 358 to 1       358/358
(100 %)
3 diff
(99.2 %id)
CA390696 eye, RPE/choroid FARP1.a 1956 to 2503 1 to 548   tiling clone,   548/548
(100 %)
2 diff
(99.7 %id)
BM705217 eye, RPE and Choroid FARP1.a 1997 to 2492 1 to 496     Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 496/496
(100 %)
1 diff
(99.8 %id)
BG960609 colon FARP1.a 2052 to 2293 241 to 1       241/241
(100 %)
4 diff
(98.4 %id)
BG960655 colon FARP1.a 2052 to 2293 244 to 2       243/244
(99 %)
0 diff
(100 %id)
BG961015 colon FARP1.a 2052 to 2293 244 to 2       243/244
(99 %)
0 diff
(100 %id)
BG961680 colon FARP1.a 2052 to 2293 244 to 2       243/244
(99 %)
0 diff
(100 %id)
D81819 brain FARP1.a 2130 to 2479 1 to 351       351/351
(100 %)
2 diff
(99.5 %id)
Z41902 brain, total brain FARP1.a 2167 to 2428 1 to 261       261/261
(100 %)
1 diff
(99.7 %id)
BF831432 head_neck FARP1.a 2174 to 2360 196 to 8     Submitted on the opposite strand 189/196
(96 %)
0 diff
(100 %id)
BX364605 Neuroblastoma Cot 25-normalized FARP1.a 2607 to 3559 951 to 1       951/951
(100 %)
6 diff
(99.4 %id)
BF206296 brain, neuroblastoma FARP1.a 2629 to 3386 1 to 759       759/883
(85 %)
20 diff
(97.8 %id)
AL566821 brain, fetal brain FARP1.a 2650 to 3576 930 to 1       927/930
(99 %)
12 diff
(98.8 %id)
AA351717 brain FARP1.a 2655 to 2852 1 to 198       198/198
(100 %)
0 diff
(100 %id)
AW806689 stomach FARP1.a 2667 to 3042 376 to 1       376/377
(99 %)
4 diff
(99.0 %id)
BF793662 adrenal cortex carcinoma, cell line, adrenal gland FARP1.a 2681 to 3390 1 to 710       710/736
(96 %)
1 diff
(99.9 %id)
DA517148 brain FARP1.a 2682 to 3181 2 to 501   capped   500/500
(100 %)
1 diff
(99.8 %id)
BX337592 Placenta Cot 25-normalized FARP1.a 2727 to 3538 809 to 1       809/809
(100 %)
4 diff
(99.6 %id)
DA056870 cerebellum FARP1.a 2728 to 3286 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BG171514 hypernephroma, cell line, Kidney FARP1.a 2744 to 3518 1 to 765       765/981
(77 %)
18 diff
(98.2 %id)
BQ711629 Spleen FARP1.a 2744 to 3588 11 to 853       843/987
(85 %)
29 diff
(97.1 %id)
TI_227715764   FARP1.a 2781 to 3590 886 to 84   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 803/1009
(79 %)
23 diff
(97.8 %id)
TI_151760267   FARP1.a 2781 to 3590 883 to 83   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 801/924
(86 %)
19 diff
(98.0 %id)
BG698789 skin FARP1.a 2784 to 3469 1 to 689       687/690
(99 %)
12 diff
(98.3 %id)
BM927159 brain FARP1.a 2814 to 3696 1 to 887       887/1061
(83 %)
14 diff
(98.7 %id)
AL121329 melanoma (MeWo cell line) FARP1.a 2835 to 3193 1 to 359       359/359
(100 %)
1 diff
(99.8 %id)
TI_149285973   FARP1.a 2840 to 3594 835 to 86   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 750/805
(93 %)
12 diff
(98.6 %id)
TI_154113144   FARP1.a 2840 to 3571 816 to 87   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 730/946
(77 %)
8 diff
(99.2 %id)
CA444708 lung, Metastatic Chondrosarcoma FARP1.a 2840 to 3595 772 to 19   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 754/777
(97 %)
9 diff
(98.9 %id)
CN291629 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells FARP1.a 2851 to 3421 1 to 571       571/571
(100 %)
0 diff
(100 %id)
CA448733 Chondrosarcoma, Left Pelvis FARP1.a 2858 to 3571 731 to 19   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 713/713
(100 %)
3 diff
(99.6 %id)
ES308177 beard hair, skin FARP1.a 2864 to 3019 1 to 156       156/156
(100 %)
0 diff
(100 %id)
TI_149281885   FARP1.a 2879 to 3595 801 to 86   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 716/717
(99 %)
14 diff
(98.1 %id)
DA596160   FARP1.a 2887 to 3408 2 to 523   capped   522/522
(100 %)
2 diff
(99.7 %id)
AI907882 breast FARP1.a 2904 to 3470 581 to 16       566/582
(97 %)
3 diff
(99.5 %id)
BM971809 lung FARP1.a 2941 to 3594 672 to 19   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 654/654
(100 %)
0 diff
(100 %id)
CD366873 Alveolar Macrophage, lung FARP1.a 2942 to 3590 664 to 16   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 649/649
(100 %)
1 diff
(99.9 %id)
BM688535 eye, eye anterior segment FARP1.a 2973 to 3419 9 to 455   fully sequenced, Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 447/455
(98 %)
6 diff
(98.7 %id)
BM707946 eye, RPE and Choroid FARP1.a 2981 to 3528 1 to 548   fully sequenced, Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 548/548
(100 %)
2 diff
(99.7 %id)
AW411446 muscle, rhabdomyosarcoma FARP1.a 3034 to 3595 580 to 19   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 562/562
(100 %)
4 diff
(99.3 %id)
AI139282 uterus FARP1.a 3075 to 3566 492 to 1       492/492
(100 %)
1 diff
(99.8 %id)
BU731806 eye, RPE and Choroid FARP1.a 3098 to 3553 474 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 456/456
(100 %)
2 diff
(99.6 %id)
DB522695 testis FARP1.a 3107 to 3571 1 to 465     Submitted on the opposite strand 465/465
(100 %)
1 diff
(99.8 %id)
AA404224 ovarian tumor, ovary FARP1.a 3108 to 3566 1 to 459   fully sequenced,   459/459
(100 %)
0 diff
(100 %id)
AA456162 ovarian tumor, ovary FARP1.a 3108 to 3561 1 to 454   fully sequenced,   454/454
(100 %)
2 diff
(99.6 %id)
CD621143   FARP1.a 3111 to 3426 14 to 329       316/339
(93 %)
14 diff
(95.9 %id)
CD621144   FARP1.a 3111 to 3426 325 to 10       316/338
(93 %)
9 diff
(97.4 %id)
T81405 liver and spleen FARP1.a 3127 to 3321 9 to 209   fully sequenced,   201/209
(96 %)
0 diff
(100 %id)
AI076485   FARP1.a 3129 to 3591 465 to 3       463/465
(99 %)
0 diff
(100 %id)
BU533895 mixed (pool of 40 RNAs) FARP1.a 3152 to 3590 1 to 439       439/443
(99 %)
4 diff
(99.1 %id)
AI248234 liver and spleen FARP1.a 3153 to 3594 442 to 1       442/442
(100 %)
1 diff
(99.8 %id)
AI377114   FARP1.a 3156 to 3590 447 to 13   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 435/435
(100 %)
3 diff
(99.4 %id)
AA535701 colon FARP1.a 3162 to 3571 410 to 1       410/410
(100 %)
0 diff
(100 %id)
AW969562   FARP1.a 3168 to 3571 1 to 404   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 404/404
(100 %)
0 diff
(100 %id)
BU736795 eye, RPE and Choroid FARP1.a 3172 to 3594 441 to 19   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 423/423
(100 %)
2 diff
(99.6 %id)
AA227168 brain, neuroepithelial cells FARP1.a 3199 to 3590 392 to 1       392/392
(100 %)
1 diff
(99.8 %id)
AA493303 thyroid FARP1.a 3212 to 3576 375 to 12       364/377
(96 %)
4 diff
(99.0 %id)
BQ029503 lung, Metastatic Chondrosarcoma FARP1.a 3237 to 3590 372 to 19   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 354/354
(100 %)
1 diff
(99.8 %id)
BI015441 lung_tumor FARP1.a 3260 to 3548 293 to 6       288/297
(96 %)
0 diff
(100 %id)
AU118571 whole embryo, mainly head FARP1.a 3263 to 4114 2 to 852   capped   851/851
(100 %)
3 diff
(99.7 %id)
AA459622 ovarian tumor, ovary FARP1.a 3275 to 3685 2 to 411       410/411
(99 %)
5 diff
(98.8 %id)
AA410728 ovarian tumor, ovary FARP1.a 3278 to 3700 1 to 423       423/423
(100 %)
4 diff
(99.1 %id)
T81406 liver and spleen FARP1.a 3291 to 3594 307 to 3   fully sequenced,   305/307
(99 %)
0 diff
(100 %id)
BU532439 mixed (pool of 40 RNAs) FARP1.a 3313 to 3733 1 to 421       421/423
(99 %)
3 diff
(99.3 %id)
AW067775 Bone, Hip FARP1.a 3313 to 3714 410 to 9       402/410
(98 %)
0 diff
(100 %id)
AA443095 ovarian tumor, ovary FARP1.a 3358 to 3572 215 to 1   fully sequenced,   215/215
(100 %)
0 diff
(100 %id)
BU727109 eye, eye anterior segment FARP1.a 3358 to 3571 232 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 214/214
(100 %)
1 diff
(99.6 %id)
BI868337 adenocarcinoma, cell line, Liver FARP1.a 3364 to 4206 1 to 847       847/848
(99 %)
25 diff
(97.1 %id)
CR737589 liver and spleen FARP1.a 3378 to 4158 1 to 780       780/782
(99 %)
2 diff
(99.8 %id)
Z38199 brain, total brain FARP1.a 3379 to 3590 215 to 1       215/216
(99 %)
8 diff
(96.3 %id)
AA404608 ovarian tumor, ovary FARP1.a 3462 to 3572 111 to 1   fully sequenced,   111/111
(100 %)
1 diff
(99.1 %id)
CN289671 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FARP1.a 3706 to 4514 1 to 806       806/806
(100 %)
8 diff
(99.1 %id)
AW118117 pooled FARP1.a 3822 to 4604 1 to 770     Submitted on the opposite strand 770/819
(94 %)
6 diff
(99.3 %id)
BC053593 Brain, hippocampus FARP1.a 3875 to 4915 1 to 1041   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 1041/1041
(100 %)
0 diff
(100 %id)
BM545325 brain, hippocampus FARP1.a 3875 to 4801 27 to 955   available from MGC,   929/1089
(85 %)
36 diff
(96.7 %id)
CD356758 Blood vessels - aorta, basilar and artery FARP1.a 3878 to 4588 1 to 720       720/768
(93 %)
18 diff
(97.7 %id)
CB985222 Pooled-Glandular FARP1.a 3885 to 4584 1 to 707       707/752
(94 %)
14 diff
(98.2 %id)
CR742680 uterus FARP1.a 3907 to 4632 1 to 729       729/729
(100 %)
6 diff
(99.2 %id)
AA203222 liver and spleen FARP1.a 3911 to 4569 1 to 652       652/905
(72 %)
16 diff
(98.3 %id)
TI_149297476   FARP1.a 3925 to 4920 1053 to 78   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 976/1002
(97 %)
33 diff
(96.8 %id)
BM968923 lung, Primary Lung Epithelial Cells FARP1.a 3951 to 4468 1 to 518     Submitted on the opposite strand 518/518
(100 %)
4 diff
(99.3 %id)
CA314943 Human Lung Epithelial cells, lung FARP1.a 3957 to 4636 1 to 679     Submitted on the opposite strand 679/688
(98 %)
4 diff
(99.5 %id)
TI_149311816   FARP1.a 4026 to 4920 972 to 87   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 886/958
(92 %)
15 diff
(98.5 %id)
AA084244   FARP1.a 4096 to 4458 1 to 369     Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 369/369
(100 %)
6 diff
(98.4 %id)
CD722767 eye, lacrimal gland FARP1.a 4114 to 4724 1 to 611       611/611
(100 %)
2 diff
(99.7 %id)
CN478935 Human Lung Epithelial cells, lung FARP1.a 4147 to 4889 759 to 17   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 743/743
(100 %)
2 diff
(99.8 %id)
BQ007730 Chondrosarcoma, Left Pelvis FARP1.a 4167 to 4920 766 to 14   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 753/753
(100 %)
1 diff
(99.9 %id)
BU622088 Cell Line, Chondrosarcoma FARP1.a 4167 to 4889 739 to 17   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 723/723
(100 %)
0 diff
(100 %id)
CB850636 lung, Primary Lung Cystic Fibrosis EpithelialCells FARP1.a 4178 to 4920 755 to 14   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 742/742
(100 %)
1 diff
(99.9 %id)
BQ015258 Chondrosarcoma, Left Pubic Bone FARP1.a 4179 to 4920 754 to 14   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 741/741
(100 %)
2 diff
(99.8 %id)
BM977575 lung, Primary Lung Cystic Fibrosis EpithelialCells FARP1.a 4182 to 4920 751 to 14   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 738/738
(100 %)
1 diff
(99.9 %id)
CA439821 lung, Lung Focal Fibrosis FARP1.a 4184 to 4889 723 to 19   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 705/705
(100 %)
2 diff
(99.8 %id)
TI_153949226   FARP1.a 4196 to 4874 73 to 747       675/959
(70 %)
10 diff
(99.0 %id)
CB163539 Liver FARP1.a 4197 to 4826 1 to 628       628/628
(100 %)
2 diff
(99.7 %id)
AI701049 adenocarcinoma, Pancreas FARP1.a 4203 to 4922 712 to 1       712/712
(100 %)
27 diff
(96.3 %id)
TI_149304167   FARP1.a 4232 to 4920 770 to 82   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 689/690
(99 %)
1 diff
(99.9 %id)
CA449835 Chondrosarcoma, Left Pelvis FARP1.a 4235 to 4920 699 to 14   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 686/686
(100 %)
1 diff
(99.9 %id)
AA044325 uterus FARP1.a 4244 to 4405 1 to 163       163/163
(100 %)
2 diff
(98.8 %id)
CB851126 lung, Primary Lung Cystic Fibrosis EpithelialCells FARP1.a 4252 to 4920 682 to 14   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 669/669
(100 %)
1 diff
(99.9 %id)
BM662940 eye, RPE and Choroid FARP1.a 4257 to 4920 681 to 18   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 664/664
(100 %)
0 diff
(100 %id)
BQ774416 Chondrosarcoma Grade II, Left Pelvis FARP1.a 4258 to 4920 681 to 19   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 663/663
(100 %)
0 diff
(100 %id)
CF129101 Chondrosarcoma Lung Metastasis cell lines, lung FARP1.a 4309 to 4893 1 to 585       585/585
(100 %)
4 diff
(99.4 %id)
BM929606 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid FARP1.a 4324 to 4889 1 to 566       566/566
(100 %)
0 diff
(100 %id)
AW841119 colon_normal FARP1.a 4332 to 4818 500 to 13       488/501
(97 %)
0 diff
(100 %id)
DB356719 whole embryo, mainly head FARP1.a 4344 to 4889 545 to 1       545/545
(100 %)
12 diff
(97.8 %id)
H44556 breast FARP1.a 4374 to 4614 1 to 242   fully sequenced,   242/242
(100 %)
0 diff
(100 %id)
CA437959 lung, Metastatic Chondrosarcoma FARP1.a 4388 to 4889 518 to 17   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 502/510
(98 %)
0 diff
(100 %id)
AI417172 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FARP1.a 4393 to 4891 515 to 17       499/515
(96 %)
0 diff
(100 %id)
AI807086 pooled FARP1.a 4415 to 4868 454 to 1       454/454
(100 %)
1 diff
(99.8 %id)
AI870203 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors FARP1.a 4415 to 4889 475 to 1       475/475
(100 %)
0 diff
(100 %id)
AI590934 normal gingiva (cell line from immortalizedkeratinocytes) FARP1.a 4416 to 4918 504 to 1       504/504
(100 %)
1 diff
(99.9 %id)
AA593879 colon, colon tumor FARP1.a 4428 to 4919 492 to 1       492/492
(100 %)
1 diff
(99.8 %id)
AL121561 melanoma (MeWo cell line) FARP1.a 4431 to 4915 1 to 486       486/486
(100 %)
2 diff
(99.6 %id)
CK820466 insulinoma, Pancreas FARP1.a 4436 to 4920 502 to 18   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 485/485
(100 %)
0 diff
(100 %id)
AI128029 uterus FARP1.a 4437 to 4922 487 to 2       486/487
(99 %)
0 diff
(100 %id)
AI923014 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors FARP1.a 4438 to 4922 488 to 4       485/488
(99 %)
0 diff
(100 %id)
AA496796   FARP1.a 4439 to 4925 486 to 1       486/486
(100 %)
3 diff
(99.4 %id)
AI304337 adenocarcinoma, colon FARP1.a 4442 to 4921 480 to 1       480/480
(100 %)
3 diff
(99.4 %id)
AI478646 Kidney FARP1.a 4446 to 4926 481 to 1       481/481
(100 %)
1 diff
(99.8 %id)
AA701433 liver and spleen FARP1.a 4465 to 4920 455 to 1       455/455
(100 %)
2 diff
(99.6 %id)
CB158638 Liver FARP1.a 4470 to 4926 467 to 11     Submitted on the opposite strand 457/467
(97 %)
0 diff
(100 %id)
AA044578 uterus FARP1.a 4473 to 4889 418 to 1       418/418
(100 %)
1 diff
(99.8 %id)
DB548733 hippocampus FARP1.a 4474 to 4920 1 to 447     Submitted on the opposite strand 447/447
(100 %)
0 diff
(100 %id)
AW439837 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus FARP1.a 4477 to 4921 445 to 1       445/445
(100 %)
0 diff
(100 %id)
AI361387 brain, glioblastoma (pooled) FARP1.a 4483 to 4915 433 to 1       433/433
(100 %)
0 diff
(100 %id)
AI637484 pooled germ cell tumors FARP1.a 4486 to 4926 442 to 2       441/442
(99 %)
0 diff
(100 %id)
AA505987 breast FARP1.a 4501 to 4924 425 to 1       425/425
(100 %)
1 diff
(99.8 %id)
AA668842 lung FARP1.a 4508 to 4880 373 to 1       373/373
(100 %)
2 diff
(99.5 %id)
AI890282 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus FARP1.a 4510 to 4924 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AA084245   FARP1.a 4535 to 4920 403 to 18   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 386/387
(99 %)
0 diff
(100 %id)
AA478341 ovarian tumor, ovary FARP1.a 4535 to 4912 1 to 378   fully sequenced,   378/378
(100 %)
2 diff
(99.5 %id)
AW191864 adenocarcinoma, Pancreas FARP1.a 4541 to 4926 388 to 3       386/388
(99 %)
0 diff
(100 %id)
AI193762 lung FARP1.a 4550 to 4888 339 to 1       339/339
(100 %)
1 diff
(99.8 %id)
BU589760 mixed (pool of 40 RNAs) FARP1.a 4559 to 4920 1 to 362       362/363
(99 %)
1 diff
(99.8 %id)
BF941837 fibrotheoma, ovary FARP1.a 4568 to 4920 353 to 1       353/353
(100 %)
1 diff
(99.8 %id)
AA402639 ovarian tumor, ovary FARP1.a 4569 to 4920 352 to 1       352/352
(100 %)
1 diff
(99.8 %id)
AA459397 ovarian tumor, ovary FARP1.a 4572 to 4889 318 to 1       318/318
(100 %)
1 diff
(99.7 %id)
H44557 breast FARP1.a 4584 to 4908 331 to 1   fully sequenced,   331/331
(100 %)
1 diff
(99.7 %id)
AI905380 breast FARP1.a 4607 to 4886 280 to 1       280/280
(100 %)
1 diff
(99.7 %id)
AA613575 colon, colon tumor RER+ FARP1.a 4610 to 4922 315 to 3       313/315
(99 %)
0 diff
(100 %id)
AI767281 Kidney FARP1.a 4627 to 4920 294 to 1       294/294
(100 %)
0 diff
(100 %id)
CA414321 Chondrosarcoma Grade II, Left Pelvis FARP1.a 4634 to 4920 305 to 19   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 287/287
(100 %)
0 diff
(100 %id)
AA478282 ovarian tumor, ovary FARP1.a 4667 to 4920 254 to 1   fully sequenced,   254/254
(100 %)
1 diff
(99.7 %id)
AA235731 ovarian tumor, ovary FARP1.a 4672 to 4889 218 to 1       218/218
(100 %)
1 diff
(99.6 %id)
AA722781 heart FARP1.a 4694 to 4921 228 to 1       228/228
(100 %)
0 diff
(100 %id)
AA069699   FARP1.a 4710 to 4889 193 to 14   AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 180/180
(100 %)
0 diff
(100 %id)
DB498534 hypothalamus FARP1.b 1 to 502 1 to 502   tiling clone,   502/503
(99 %)
4 diff
(99.3 %id)
CF994038 Human Placenta, placenta FARP1.b 13 to 594 28 to 609       582/732
(79 %)
10 diff
(98.7 %id)
AW190412 adenocarcinoma, Pancreas FARP1.b 82 to 594 1 to 513     Submitted on the opposite strand 513/533
(96 %)
19 diff
(96.5 %id)
AI273567 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FARP1.b 83 to 510 1 to 428     Submitted on the opposite strand 428/428
(100 %)
0 diff
(100 %id)
BF195016 fibrotheoma, ovary FARP1.b 83 to 652 1 to 570     Submitted on the opposite strand 570/570
(100 %)
4 diff
(99.3 %id)
NM_005766.2   FARP1.b 83 to 5001 1 to 4919 exact RefSeq, AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 4919/4919
(100 %)
0 diff
(100 %id)
AI091437 pooled FARP1.b 101 to 670 1 to 570     Submitted on the opposite strand 570/570
(100 %)
1 diff
(99.9 %id)
BC041595 Brain, astrocytoma, grade IV FARP1.b 154 to 3681 1 to 3528 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 3528/3528
(100 %)
2 diff
(100.0 %id)
BM549907 astrocytoma grade IV, cell line, brain FARP1.b 154 to 1081 1 to 939       937/995
(94 %)
16 diff
(98.4 %id)
DN997649 breast cancer, Mammary gland (cancer tissue) FARP1.b 232 to 896 9 to 673       665/673
(98 %)
0 diff
(100 %id)
CN291622 embryonic stem cells, cell lines H1, H7, andH9 FARP1.b 252 to 816 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
CN291618 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells FARP1.b 261 to 696 1 to 436       436/438
(99 %)
3 diff
(99.4 %id)
BF940343 fibrotheoma, ovary FARP1.b 296 to 594 35 to 333     Submitted on the opposite strand 299/472
(63 %)
10 diff
(97.9 %id)
AB008430 cartilage FARP1.b 371 to 3812 1 to 3442 exact tiling clone,   3442/3442
(100 %)
2 diff
(100.0 %id)
BQ706499 Spleen FARP1.b 1990 to 2847 1 to 862       862/926
(93 %)
14 diff
(98.5 %id)
BX350128 Placenta Cot 25-normalized FARP1.b 2107 to 2964 856 to 1       856/857
(99 %)
1 diff
(99.9 %id)
BU146764 brain, neuroblastoma, cell line FARP1.b 2110 to 2990 25 to 910       886/966
(91 %)
19 diff
(98.1 %id)
BQ072025 brain, neuroblastoma, cell line FARP1.b 2111 to 2943 1 to 835       835/1043
(80 %)
15 diff
(98.6 %id)
DA201997 brain FARP1.b 2126 to 2700 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
BG750463 eye, normal pigmented retinal epithelium FARP1.b 2126 to 2900 1 to 788       788/788
(100 %)
30 diff
(96.2 %id)
CN291619 embryonic stem cells, DMSO-treated H9 cellline FARP1.b 2154 to 2815 1 to 664       664/664
(100 %)
7 diff
(99.0 %id)
BQ674703 epidermoid carcinoma, cell line, salivary gland FARP1.b 2177 to 2932 1 to 757       757/988
(76 %)
7 diff
(99.3 %id)
BP307837 brain FARP1.b 2180 to 2781 1 to 603       603/603
(100 %)
11 diff
(98.2 %id)
CD621142   FARP1.b 2206 to 2940 747 to 7       750/747
(100 %)
59 diff
(92.2 %id)
CN291626 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells FARP1.b 2206 to 2944 1 to 741       741/741
(100 %)
5 diff
(99.4 %id)
BE907778 epithelioid carcinoma, Pancreas FARP1.b 2206 to 2887 1 to 690       690/890
(77 %)
18 diff
(98.0 %id)
BQ646351 hepatocellular carcinoma, cell line, Liver FARP1.b 2218 to 2862 1 to 646       646/909
(71 %)
11 diff
(98.8 %id)
CD621140   FARP1.b 2219 to 2940 734 to 8       736/734
(100 %)
61 diff
(91.7 %id)
AL121548 melanoma (MeWo cell line) FARP1.b 2227 to 2714 1 to 489       489/489
(100 %)
2 diff
(99.6 %id)
BG764061 melanotic melanoma, high MDR (cell line), skin FARP1.b 2279 to 3130 1 to 847       847/861
(98 %)
16 diff
(98.2 %id)
BG770181 melanotic melanoma, high MDR (cell line), skin FARP1.b 2279 to 2897 1 to 621       621/621
(100 %)
2 diff
(99.7 %id)
DA260089 caudate nucleus FARP1.b 2364 to 2927 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA992012 synovial membrane tissue from rheumatioidarthritis FARP1.b 2364 to 2898 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DA309040 hippocampus FARP1.b 2365 to 2934 2 to 571   capped   570/571
(99 %)
0 diff
(100 %id)
BP240161 Liver FARP1.b 2369 to 2927 1 to 559       559/559
(100 %)
4 diff
(99.3 %id)
BP256829 Kidney FARP1.b 2369 to 2951 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BP256831 Kidney FARP1.b 2369 to 2950 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BP256832 Kidney FARP1.b 2369 to 2949 1 to 580       580/580
(100 %)
5 diff
(99.2 %id)
R14694.
matches multiple genes
whole brain FARP1.b 2390 to 2761 1 to 374     Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base), also hits gene PPP1R9A 374/466
(80 %)
11 diff
(97.7 %id)
CN291621 embryonic stem cells, DMSO-treated H9 cellline FARP1.b 2406 to 3029 1 to 624       624/624
(100 %)
0 diff
(100 %id)
BG420356 Kidney, renal cell adenocarcinoma FARP1.b 2407 to 3039 1 to 633       633/861
(73 %)
11 diff
(98.8 %id)
BM551766 astrocytoma grade IV, cell line, brain FARP1.b 2415 to 3417 1 to 1020       1020/1026
(99 %)
23 diff
(97.8 %id)
DA778838 brain FARP1.b 2420 to 3002 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
BQ301106 bocio_tumor FARP1.b 2451 to 2877 37 to 475       439/475
(92 %)
10 diff
(97.9 %id)
BQ367501 placenta_normal FARP1.b 2465 to 2761 22 to 321       300/323
(92 %)
13 diff
(96.0 %id)
DA381601 thalamus FARP1.b 2487 to 3110 2 to 626   capped   625/625
(100 %)
2 diff
(99.7 %id)
DA596566   FARP1.b 2505 to 2973 2 to 470   capped   469/469
(100 %)
0 diff
(100 %id)
CN291615 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells FARP1.b 2517 to 3112 1 to 595       595/595
(100 %)
2 diff
(99.7 %id)
BG122769 adenocarcinoma, cell line, Liver FARP1.b 2530 to 3235 1 to 705       705/741
(95 %)
34 diff
(95.5 %id)
BE271866 adenocarcinoma cell line, ovary FARP1.b 2568 to 2981 1 to 414       414/414
(100 %)
0 diff
(100 %id)
BE746268 adenocarcinoma cell line, ovary FARP1.b 2569 to 3474 1 to 903       903/1122
(80 %)
16 diff
(98.6 %id)
CN291623 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FARP1.b 2582 to 2981 1 to 400       400/400
(100 %)
0 diff
(100 %id)
BX354920 Neuroblastoma Cot 25-normalized FARP1.b 2589 to 3648 1050 to 1       1050/1072
(97 %)
20 diff
(98.2 %id)
BQ683731 melanotic melanoma, cell line, skin FARP1.b 2597 to 3220 1 to 627       627/994
(63 %)
69 diff
(93.1 %id)
BQ676703 melanotic melanoma, cell line, skin FARP1.b 2602 to 3148 1 to 549       549/970
(56 %)
12 diff
(98.8 %id)
BQ681261 melanotic melanoma, cell line, skin FARP1.b 2602 to 3292 1 to 694       694/890
(77 %)
10 diff
(98.9 %id)
BQ679905 melanotic melanoma, cell line, skin FARP1.b 2602 to 3230 1 to 628       628/959
(65 %)
10 diff
(99.0 %id)
BU179876 melanotic melanoma, cell line, skin FARP1.b 2602 to 3376 1 to 782       782/942
(83 %)
8 diff
(99.2 %id)
BQ676994 melanotic melanoma, cell line, skin FARP1.b 2602 to 3408 1 to 813       813/952
(85 %)
16 diff
(98.4 %id)
BI051634 placenta_normal FARP1.b 2612 to 2915 1 to 304       304/304
(100 %)
0 diff
(100 %id)
AA425178   FARP1.b 2622 to 3066 1 to 443       443/443
(100 %)
2 diff
(99.6 %id)
BU174449 melanotic melanoma, cell line, skin FARP1.b 2626 to 3475 1 to 853       853/889
(95 %)
9 diff
(99.0 %id)
BU163030 melanotic melanoma, cell line, skin FARP1.b 2626 to 3455 1 to 836       836/881
(94 %)
15 diff
(98.3 %id)
R06234 liver and spleen FARP1.b 2640 to 2780 1 to 144       142/144
(98 %)
5 diff
(96.6 %id)
AI683520 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors FARP1.b 2645 to 3151 1 to 507     Submitted on the opposite strand 507/507
(100 %)
0 diff
(100 %id)
DB020463 testis FARP1.b 2648 to 3195 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
AA489290   FARP1.b 2656 to 3102 1 to 441     Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 441/442
(99 %)
11 diff
(97.6 %id)
BM708762 eye, RPE and Choroid FARP1.b 2667 to 3146 1 to 481       481/481
(100 %)
3 diff
(99.4 %id)
AA486435   FARP1.b 3194 to 3681 506 to 20   tiling clone, AAA Possibly primed on the genome, locally A rich (21/23 A in genome downstream of last aligned base) 487/487
(100 %)
1 diff
(99.8 %id)
AA479935   FARP1.b 3213 to 3677 470 to 6       465/474
(98 %)
1 diff
(99.8 %id)
BE176474 head_neck FARP1.c 1 to 596 608 to 15   tiling clone, Submitted on the opposite strand 594/617
(96 %)
2 diff
(99.7 %id)
AA059481 cornea FARP1.c 396 to 533 1 to 138       138/140
(98 %)
2 diff
(98.6 %id)
BQ221203 melanotic melanoma, skin FARP1.c 1779 to 2542 786 to 16   tiling clone, AAA Submitted on the opposite strand 771/861
(89 %)
12 diff
(98.7 %id)
AI290936 carcinoid, lung FARP1.c 1881 to 2324 52 to 495   tiling clone, Submitted on the opposite strand 444/495
(89 %)
0 diff
(100 %id)
AI298217 carcinoid, lung FARP1.c 1881 to 2264 52 to 435     Submitted on the opposite strand 384/435
(88 %)
0 diff
(100 %id)
AI701115 carcinoid, lung FARP1.c 1881 to 2315 12 to 446     Submitted on the opposite strand 435/446
(97 %)
6 diff
(98.7 %id)
BE673853 carcinoid, lung FARP1.c 1881 to 2300 53 to 472     Submitted on the opposite strand 420/472
(88 %)
0 diff
(100 %id)
BF447678 carcinoid, lung FARP1.c 1881 to 2318 53 to 490     Submitted on the opposite strand 438/490
(89 %)
2 diff
(99.6 %id)
AA059482 cornea FARP1.c 1966 to 2352 393 to 5       389/393
(98 %)
1 diff
(99.8 %id)
AI086045 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FARP1.c 2040 to 2543 513 to 10       504/513
(98 %)
0 diff
(100 %id)
DB525433 testis FARP1.c 2111 to 2548 1 to 438   tiling clone, Submitted on the opposite strand 438/438
(100 %)
0 diff
(100 %id)
DA570428 whole embryo, mainly head FARP1.d 1 to 785 2 to 785   tiling clone, to resequence, capped   784/784
(100 %)
6 diff
(99.3 %id)
AI589743 adenocarcinoma, Pancreas FARP1.d 272 to 623 1 to 352     Submitted on the opposite strand 352/352
(100 %)
0 diff
(100 %id)
DB357196 whole embryo, mainly head FARP1.d 1274 to 1803 529 to 1   tiling clone, to resequence,   529/530
(99 %)
3 diff
(99.5 %id)
CN291628 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 FARP1.e 1 to 742 9 to 750 exact tiling clone,   750/750
(100 %)
4 diff
(99.5 %id)
AI863628 Kidney FARP1.f 1 to 364 366 to 1   tiling clone,   366/366
(100 %)
2 diff
(99.5 %id)
DA414056 thalamus FARP1.f 22 to 589 2 to 570   tiling clone, capped   569/569
(100 %)
2 diff
(99.7 %id)
CB122265 Liver FARP1.f 331 to 884 1 to 554   tiling clone,   554/554
(100 %)
3 diff
(99.5 %id)
DA445176 tongue, tumor tissue FARP1.f 610 to 1191 2 to 584   tiling clone, capped   583/583
(100 %)
2 diff
(99.7 %id)
DB313929 tongue, tumor tissue FARP1.f 1879 to 2408 530 to 1   tiling clone,   530/532
(99 %)
0 diff
(100 %id)
CD722844 eye, lacrimal gland FARP1.g 1 to 628 1 to 628 exact tiling clone,   628/628
(100 %)
0 diff
(100 %id)
CB153689 brain FARP1.g 12 to 639 1 to 628   AAA   628/628
(100 %)
1 diff
(99.9 %id)
BM994979 Chondrosarcoma, Left Pubic Bone FARP1.g 26 to 636 628 to 19   AAA   610/610
(100 %)
2 diff
(99.7 %id)
BU632017 cell lines, Chondrosarcoma FARP1.g 27 to 636 628 to 19   AAA   610/610
(100 %)
1 diff
(99.9 %id)
BM983488 lung FARP1.g 35 to 641 624 to 19   AAA   606/606
(100 %)
4 diff
(99.4 %id)
AI360995 brain, glioblastoma (pooled) FARP1.g 46 to 641 596 to 1       596/596
(100 %)
5 diff
(99.2 %id)
AW262843 brain, three pooled meningiomas FARP1.g 77 to 640 574 to 11   AAA   564/565
(99 %)
1 diff
(99.9 %id)
TI_154024942   FARP1.g 85 to 639 620 to 66   AAA   555/701
(79 %)
1 diff
(99.9 %id)
AU144714.
matches multiple genes
whole embryo, mainly head FARP1.g 88 to 636 553 to 1     also hits gene CADM2 553/559
(98 %)
15 diff
(97.4 %id)
AA557391 breast FARP1.g 112 to 640 561 to 33   AAA   529/529
(100 %)
5 diff
(99.1 %id)
BX111709 whole brain FARP1.g 169 to 636 481 to 15   AAA   467/467
(100 %)
2 diff
(99.6 %id)
AA916235 Kidney FARP1.g 169 to 641 473 to 1       473/473
(100 %)
4 diff
(99.2 %id)
AI083511 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FARP1.g 169 to 640 482 to 11   AAA   472/472
(100 %)
1 diff
(99.8 %id)
CX760914 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass FARP1.g 598 to 1349 1 to 739     Submitted on the opposite strand 739/845
(87 %)
10 diff
(98.9 %id)
DA570944 whole embryo, mainly head FARP1.g 618 to 1421 2 to 804   tiling clone, capped   803/803
(100 %)
6 diff
(99.3 %id)
N46458.
matches multiple genes
melanocyte FARP1.g 619 to 804 1 to 186     also hits gene PPP2CB 186/186
(100 %)
0 diff
(100 %id)
AI418595 pooled FARP1.g 864 to 1293 1 to 425     Submitted on the opposite strand 425/425
(100 %)
4 diff
(99.1 %id)
AW838413 leiomios FARP1.g 871 to 1105 243 to 8       236/247
(95 %)
0 diff
(100 %id)
BI064005 uterus_tumor FARP1.g 970 to 1404 1 to 435       435/435
(100 %)
0 diff
(100 %id)
CA434255 lung, Lung Focal Fibrosis FARP1.g 1013 to 1287 1 to 275   AAA Submitted on the opposite strand 275/275
(100 %)
7 diff
(97.5 %id)
CD675885 eye, lens FARP1.g 1073 to 1582 1 to 510   tiling clone,   510/510
(100 %)
0 diff
(100 %id)
AW884851 ovary FARP1.g 1179 to 1435 269 to 13       257/283
(90 %)
0 diff
(100 %id)
AW378025 head_neck FARP1.h 1 to 416 434 to 15   tiling clone,   420/442
(95 %)
19 diff
(95.8 %id)
AW377842 head_neck FARP1.h 2 to 417 431 to 17       415/440
(94 %)
25 diff
(94.4 %id)
AW377949 head_neck FARP1.h 2 to 416 1 to 415   tiling clone,   415/434
(95 %)
12 diff
(97.3 %id)
AW377856 head_neck FARP1.h 4 to 416 7 to 435   tiling clone,   426/451
(94 %)
31 diff
(93.2 %id)
AW377971 head_neck FARP1.h 24 to 416 17 to 409   tiling clone,   393/424
(92 %)
13 diff
(97.0 %id)
BF955437 nervous_normal FARP1.h 135 to 616 480 to 4   tiling clone,   477/498
(95 %)
6 diff
(98.8 %id)
BF955445 nervous_normal FARP1.h 182 to 612 1 to 434   tiling clone,   434/436
(99 %)
13 diff
(97.1 %id)
AK123565 tongue, tumor tissue FARP1.i-u 1 to 3840 2 to 3871 H14L G57V C78R tiling clone, available from FLJ,   3871/3871
(100 %)
14 diff
(99.7 %id)
DA440810 tongue, tumor tissue FARP1.i-u 1 to 591 2 to 592 H14L G57V C78R tiling clone, capped   591/593
(99 %)
4 diff
(99.4 %id)
DW413991 Liver FARP1.i-u 2953 to 3254 17 to 318   tiling clone,   302/318
(94 %)
6 diff
(98.2 %id)
DB313691 tongue, tumor tissue FARP1.i-u 3307 to 3840 534 to 1   tiling clone,   534/534
(100 %)
1 diff
(99.9 %id)
AL699509 human skeletal muscle FARP1.j-u 1 to 577 1 to 578 N36X S37F N38K L39S L40P ... tiling clone,   578/578
(100 %)
1 diff
(99.9 %id)
AI274149 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FARP1.k 1 to 423 1 to 423 exact tiling clone, Submitted on the opposite strand 423/433
(97 %)
2 diff
(99.6 %id)
NM_001001715.2   FARP1.l 1 to 1321 1 to 1321 exact RefSeq,   1321/1321
(100 %)
0 diff
(100 %id)
BM763139 myeloma FARP1.l 175 to 761 1 to 587 T68I     587/587
(100 %)
2 diff
(99.7 %id)
BM849444 myeloma FARP1.l 175 to 724 1 to 550   tiling clone,   550/555
(99 %)
3 diff
(99.5 %id)
BM782015 myeloma FARP1.l 175 to 758 1 to 584 T68I     584/584
(100 %)
2 diff
(99.7 %id)
CR746384 melanotic melanoma, skin FARP1.l 289 to 785 6 to 502 T68I     497/502
(99 %)
7 diff
(98.7 %id)
BC065020 Skin, melanotic melanoma. FARP1.l 295 to 1319 1 to 1025 T68I available from MGC, AAA   1025/1025
(100 %)
2 diff
(99.9 %id)
BQ429857 melanotic melanoma, skin FARP1.l 298 to 1022 3 to 738 T68I available from MGC,   736/778
(94 %)
18 diff
(97.7 %id)
AA758137 pineal gland FARP1.l 322 to 689 1 to 368     Submitted on the opposite strand 368/368
(100 %)
2 diff
(99.5 %id)
BQ014327 Chondrosarcoma, Left Pubic Bone FARP1.l 617 to 1319 720 to 19   tiling clone, AAA   702/702
(100 %)
3 diff
(99.6 %id)
BE463494 Kidney FARP1.l 779 to 1319 541 to 1       541/541
(100 %)
0 diff
(100 %id)
AW771601 Kidney FARP1.l 840 to 1319 480 to 1       480/480
(100 %)
3 diff
(99.4 %id)
AW291596   FARP1.l 961 to 1319 376 to 18   AAA   359/359
(100 %)
0 diff
(100 %id)
AK095747 brain FARP1.m-u 1 to 2691 2 to 2696 S100L tiling clone, available from FLJ,   2696/2696
(100 %)
16 diff
(99.5 %id)
DA522726 brain FARP1.m-u 1 to 554 2 to 555   tiling clone, capped   554/559
(99 %)
4 diff
(99.3 %id)
AW006784 colon FARP1.m-u 32 to 521 15 to 504     Submitted on the opposite strand 490/504
(97 %)
6 diff
(98.9 %id)
DB317303 brain FARP1.m-u 2163 to 2691 529 to 1       529/530
(99 %)
1 diff
(99.9 %id)
CD244055 testis FARP1.m-u 2489 to 2765 1 to 278       278/314
(88 %)
3 diff
(99.1 %id)
AI869413 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors FARP1.m-u 2537 to 2703 167 to 1   tiling clone,   167/167
(100 %)
0 diff
(100 %id)
AV730232 hypothalamus FARP1.m-u 2618 to 3259 1 to 636   tiling clone,   636/636
(100 %)
12 diff
(98.2 %id)
DA788334 brain FARP1.n 1 to 565 2 to 566 T39I tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
DA244432 brain FARP1.o-u 1 to 583 2 to 584 T31R G56S tiling clone, capped   583/583
(100 %)
5 diff
(99.2 %id)
DB228957 trachea FARP1.o-u 395 to 974 2 to 581   capped   580/593
(97 %)
2 diff
(99.7 %id)
DA806400 brain FARP1.o-u 455 to 1021 2 to 568   tiling clone, capped   567/567
(100 %)
0 diff
(100 %id)
BF812811 colon_ins FARP1.o-u 638 to 1034 1 to 397       397/397
(100 %)
10 diff
(97.5 %id)
CD656530 Embryonic Stem cells FARP1.o-u 646 to 1412 12 to 768   tiling clone,   757/770
(98 %)
9 diff
(98.9 %id)
DA516299 brain FARP1.o-u 755 to 1312 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BF802774 colon_ins FARP1.o-u 893 to 1210 3 to 317       315/327
(96 %)
4 diff
(98.8 %id)
DA179138 amygdala FARP1.o-u 987 to 1555 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA621675 Kidney FARP1.o-u 1174 to 1718 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
DA784090 brain FARP1.o-u 1240 to 1569 2 to 331   tiling clone, capped   330/330
(100 %)
1 diff
(99.7 %id)
DA518391 brain FARP1.o-u 1338 to 1880 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
CB155334 brain FARP1.o-u 1355 to 1985 1 to 631       631/631
(100 %)
3 diff
(99.6 %id)
BQ641231 eye, normal pigmented retinal epithelium FARP1.o-u 1416 to 2307 1 to 901       901/902
(99 %)
38 diff
(95.8 %id)
DA530175 brain FARP1.o-u 1463 to 2085 2 to 624   tiling clone, capped   623/623
(100 %)
3 diff
(99.6 %id)
AU253493 neuroblastoma FARP1.o-u 1580 to 2261 18 to 697       680/700
(97 %)
8 diff
(98.9 %id)
AK025683   FARP1.o-u 1601 to 4056 1 to 2455   tiling clone, available from FLJ, AAA   2455/2455
(100 %)
5 diff
(99.8 %id)
DA618070   FARP1.o-u 1906 to 2474 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DA200495 brain FARP1.o-u 1924 to 2463 2 to 543   capped   542/542
(100 %)
4 diff
(99.3 %id)
DA871116 Prostate FARP1.o-u 1992 to 2468 2 to 478   capped   477/477
(100 %)
0 diff
(100 %id)
AL120974 melanoma (MeWo cell line) FARP1.o-u 2013 to 2502 1 to 489       489/489
(100 %)
4 diff
(99.2 %id)
AW953137   FARP1.o-u 2072 to 2497 1 to 427       427/427
(100 %)
10 diff
(97.7 %id)
DR760075 embryonic stem FARP1.o-u 2077 to 2791 1 to 715       715/715
(100 %)
5 diff
(99.4 %id)
AA349723 brain FARP1.o-u 2082 to 2541 1 to 462       462/462
(100 %)
5 diff
(99.0 %id)
BM838888 Ascites, stomach FARP1.o-u 2251 to 2550 1 to 301       301/301
(100 %)
1 diff
(99.7 %id)
TI_57229731   FARP1.o-u 2377 to 3095 80 to 797       718/718
(100 %)
3 diff
(99.6 %id)
BI870457 adenocarcinoma, cell line, Liver FARP1.o-u 2379 to 3095 1 to 716   tiling clone,   716/716
(100 %)
3 diff
(99.6 %id)
BF725251 eye, Iris FARP1.o-u 2431 to 2887 1 to 457       457/457
(100 %)
2 diff
(99.6 %id)
BF832291 head_neck FARP1.o-u 2554 to 2815 260 to 1     Submitted on the opposite strand 260/260
(100 %)
4 diff
(98.5 %id)
BF833603 head_neck FARP1.o-u 2554 to 2836 294 to 10     Submitted on the opposite strand 285/294
(96 %)
0 diff
(100 %id)
BF834287 head_neck FARP1.o-u 2554 to 2815 262 to 1     Submitted on the opposite strand 262/262
(100 %)
1 diff
(99.7 %id)
BF834971 head_neck FARP1.o-u 2554 to 2833 284 to 7     Submitted on the opposite strand 278/284
(97 %)
18 diff
(93.7 %id)
BF838834 head_neck FARP1.o-u 2554 to 2815 262 to 1     Submitted on the opposite strand 262/262
(100 %)
2 diff
(99.3 %id)
BG989686 head_neck FARP1.o-u 2561 to 2815 1 to 254       254/254
(100 %)
6 diff
(97.7 %id)
BF832167 head_neck FARP1.o-u 2563 to 2760 1 to 198       198/219
(90 %)
2 diff
(99.1 %id)
R19443 whole brain FARP1.o-u 2575 to 2967 1 to 408       408/432
(94 %)
18 diff
(95.9 %id)
AF339817   FARP1.o-u 2577 to 4056 1 to 1478   AAA   1478/1478
(100 %)
5 diff
(99.7 %id)
H05332 whole brain FARP1.o-u 2601 to 3005 1 to 412       412/450
(91 %)
10 diff
(97.8 %id)
H08468 whole brain FARP1.o-u 2660 to 3090 1 to 443       443/488
(90 %)
20 diff
(96.0 %id)
BQ354316 head_neck FARP1.o-u 2669 to 2815 5 to 151       147/151
(97 %)
6 diff
(96.1 %id)
H09222 whole brain FARP1.o-u 2708 to 3092 1 to 392       392/510
(76 %)
11 diff
(97.9 %id)
CF454697 peripheral nervous system FARP1.o-u 2807 to 3549 1 to 743       743/743
(100 %)
7 diff
(99.1 %id)
AA007159 whole brain FARP1.o-u 2810 to 3104 1 to 296       296/296
(100 %)
7 diff
(97.7 %id)
Z42506 brain, total brain FARP1.o-u 2835 to 3112 1 to 278       278/278
(100 %)
4 diff
(98.6 %id)
F06185 brain, total brain FARP1.o-u 2850 to 3090 1 to 241       241/241
(100 %)
5 diff
(98.0 %id)
H12985 whole brain FARP1.o-u 2852 to 3283 1 to 444       444/444
(100 %)
14 diff
(96.9 %id)
FN100160 breast carcinoma FARP1.o-u 2889 to 2955 1 to 67       67/67
(100 %)
0 diff
(100 %id)
AI908531 breast FARP1.o-u 2905 to 3376 6 to 477       472/477
(98 %)
10 diff
(98.0 %id)
BF516531   FARP1.o-u 2991 to 3455 5 to 470     Submitted on the opposite strand 466/470
(99 %)
6 diff
(98.8 %id)
BE931817 head_neck FARP1.o-u 3086 to 3276 14 to 202       189/208
(90 %)
8 diff
(96.2 %id)
BE931825 head_neck FARP1.o-u 3096 to 3459 26 to 386       361/391
(92 %)
5 diff
(98.8 %id)
AW779886 Kidney FARP1.o-u 3115 to 3589 503 to 28   tiling clone,   476/503
(94 %)
0 diff
(100 %id)
BQ355740 head_neck FARP1.o-u 3172 to 3747 26 to 600       575/600
(95 %)
5 diff
(99.2 %id)
BG998703 head_neck FARP1.o-u 3187 to 3806 1 to 618       618/618
(100 %)
12 diff
(98.1 %id)
BF372549 prostate_tumor FARP1.o-u 3189 to 3542 1 to 354       354/354
(100 %)
2 diff
(99.5 %id)
BF507747   FARP1.o-u 3386 to 3775 12 to 401     Submitted on the opposite strand 390/401
(97 %)
6 diff
(98.6 %id)
AU253494 neuroblastoma FARP1.o-u 3387 to 4056 699 to 27   AAA   673/674
(99 %)
23 diff
(96.6 %id)
BX095970 whole brain FARP1.o-u 3547 to 4056 522 to 15   AAA   508/508
(100 %)
1 diff
(99.9 %id)
AI028516 parathyroid gland, parathyroid tumor FARP1.o-u 3622 to 4056 449 to 17   AAA   433/433
(100 %)
3 diff
(99.4 %id)
BF725250 eye, Iris FARP1.o-u 3640 to 4056 431 to 17   AAA   415/415
(100 %)
2 diff
(99.6 %id)
BF448348 carcinoid, lung FARP1.o-u 3647 to 4058 417 to 8       410/417
(98 %)
0 diff
(100 %id)
H05284 whole brain FARP1.o-u 3653 to 4056 431 to 17   AAA   415/419
(99 %)
17 diff
(96.0 %id)
AA349722 brain FARP1.o-u 3680 to 4052 371 to 1   tiling clone,   371/371
(100 %)
2 diff
(99.5 %id)
H09164 whole brain FARP1.o-u 3680 to 4058 390 to 7       384/426
(90 %)
0 diff
(100 %id)
AA975175 Kidney FARP1.o-u 3709 to 4056 363 to 1       363/363
(100 %)
18 diff
(95.1 %id)
H08750 whole brain FARP1.o-u 3712 to 4056 366 to 17   AAA   350/424
(82 %)
11 diff
(97.5 %id)
AI696495 carcinoid, lung FARP1.o-u 3712 to 4058 348 to 4   tiling clone,   345/348
(99 %)
0 diff
(100 %id)
T17209   FARP1.o-u 3713 to 4052 338 to 1       338/338
(100 %)
2 diff
(99.5 %id)
H05625 whole brain FARP1.o-u 3732 to 4056 353 to 21   AAA   333/333
(100 %)
12 diff
(96.4 %id)
AW418891 2 pooled tumors (clear cell type), Kidney FARP1.o-u 3758 to 4058 302 to 4       299/302
(99 %)
0 diff
(100 %id)
AA007158 whole brain FARP1.o-u 3768 to 4054 287 to 2       286/287
(99 %)
0 diff
(100 %id)
Z39106 brain, total brain FARP1.o-u 3791 to 4056 263 to 1       263/263
(100 %)
3 diff
(98.9 %id)
AI913086 Kidney FARP1.o-u 3885 to 4056 170 to 1       170/170
(100 %)
3 diff
(98.3 %id)
BF195883 Kidney FARP1.o-u 3885 to 4056 170 to 1       170/170
(100 %)
1 diff
(99.5 %id)
BX106425 Kidney FARP1.p-u 1 to 482 1 to 479   tiling clone, AAA   479/479
(100 %)
3 diff
(99.4 %id)
CR740269 Kidney FARP1.p-u 1 to 482 1 to 482   AAA   482/482
(100 %)
8 diff
(98.4 %id)
AI262787 Kidney FARP1.p-u 34 to 482 447 to 1   tiling clone,   447/447
(100 %)
2 diff
(99.6 %id)
AI766153 Kidney FARP1.p-u 171 to 363 222 to 30       193/222
(86 %)
0 diff
(100 %id)
BE169357 head_neck FARP1.p-u 270 to 634 14 to 376   tiling clone,   363/376
(96 %)
6 diff
(98.5 %id)
BI545988 brain, hippocampus FARP1.p-u 588 to 1090 1 to 504   tiling clone,   504/508
(99 %)
34 diff
(93.4 %id)
TI_44165924   FARP1.p-u 591 to 1090 113 to 613       501/617
(81 %)
32 diff
(94.9 %id)
BG617325 Liver FARP1.q-u 1 to 859 1 to 864 exact tiling clone,   864/865
(99 %)
24 diff
(97.3 %id)
AW812379 stomach FARP1.r-u 1 to 529 531 to 4 P3L S4F S5L T6H S8Q ... tiling clone,   528/590
(89 %)
0 diff
(100 %id)
BX115123   FARP1.r-u 169 to 641 1 to 472   tiling clone,   472/472
(100 %)
1 diff
(99.8 %id)
AW270133 pooled FARP1.s 1 to 558 559 to 2 exact tiling clone,   558/559
(99 %)
0 diff
(100 %id)
AI208974   FARP1.s 111 to 556 458 to 13   AAA   446/449
(99 %)
0 diff
(100 %id)
AA923396 pooled FARP1.s 143 to 556 414 to 1       414/414
(100 %)
1 diff
(99.8 %id)
AA813096   FARP1.s 169 to 558 391 to 2   tiling clone,   390/391
(99 %)
0 diff
(100 %id)
AI809395 pooled FARP1.s 287 to 558 273 to 2       272/273
(99 %)
0 diff
(100 %id)
DB459989 testis FARP1.t 1 to 462 1 to 462 exact tiling clone,   462/462
(100 %)
0 diff
(100 %id)
DB457247 testis FARP1.t 46 to 523 1 to 478 exact tiling clone,   478/478
(100 %)
1 diff
(99.8 %id)
DB459869 testis FARP1.t 46 to 491 1 to 446 exact     446/446
(100 %)
0 diff
(100 %id)
AL045016 testis FARP1.t 103 to 415 1 to 313 exact     313/313
(100 %)
0 diff
(100 %id)
AI961258 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors FARP1.u-u 1 to 500 515 to 15 exact tiling clone, AAA   501/501
(100 %)
1 diff
(99.9 %id)
AI381545 pooled FARP1.va 1 to 491 495 to 5 exact tiling clone,   491/495
(99 %)
0 diff
(100 %id)
AI690075 carcinoid, lung FARP1.vb 1 to 450 450 to 1 Q6K tiling clone,   450/450
(100 %)
2 diff
(99.6 %id)
AI298784 carcinoid, lung FARP1.vb 18 to 450 433 to 1       433/433
(100 %)
1 diff
(99.8 %id)
AI937921 brain, frontal lobe FARP1.vb 18 to 457 441 to 2       440/441
(99 %)
0 diff
(100 %id)
AI879532 brain, frontal lobe FARP1.vb 81 to 451 386 to 16   tiling clone, AAA   371/383
(96 %)
3 diff
(99.3 %id)
AW593782 pooled germ cell tumors FARP1.vc 1 to 403 406 to 4 L21P tiling clone,   403/406
(99 %)
2 diff
(99.6 %id)
AW237043 pooled germ cell tumors FARP1.vc 23 to 405 384 to 2   tiling clone,   383/384
(99 %)
0 diff
(100 %id)
BX537667 human fetal kidney Gene FARP1, variant not shown       available from DKFZ, AAA This clone was ignored    
AV660941 corresponding non cancerous liver tissue Gene FARP1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
237 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j-u, .k, .l, .m-u, .n, .o-u, .p-u, .q-u, .r-u, .s, .t, .u-u, .va, .vb, .vc Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC